Wedbush Trims Biogen (NASDAQ:BIIB) Target Price to $213.00
Biogen (NASDAQ:BIIB – Free Report) had its price target decreased by Wedbush from $245.00 to $213.00 in a report released on Wednesday morning, Benzinga reports. Wedbush currently has a neutral rating on the biotechnology company’s stock. Wedbush also issued estimates for Biogen’s Q1 2024 earnings at $3.25 EPS, Q3 2024 earnings at $4.13 EPS, Q4 […]
More Stories
Netflix Has Revealed The Release Date of The Thai Drama, The Evil Lawyer
Thailand’s upcoming courtroom drama, The Evil Lawyer, will be released soon. Netflix has announced the release date. The series features...
How to Build Your First Mobile App: A Step-by-Step Guide
Discover the essential steps in mobile app development, from defining your app idea to deploying and maintaining your application. This...
Essential Tips to Optimize Your Laptop for Maximum Performance
Enhance your laptop's performance with essential strategies covering hardware components, regular maintenance, and effective software management. Discover how upgrading your...
Discover the Essentials of Blockchain Technology: An In-Depth Guide
Discover the transformative power of blockchain technology in our comprehensive guide. Explore its fundamental components, operational mechanisms, and various applications...
5 Simple and Effective Fixes to Help You Lose Weight and Achieve Your Fitness Goals
Embark on your weight loss journey with our comprehensive guide. Discover effective strategies such as meal planning, regular exercise, and...
Quick and Healthy Meal Solutions for Your Busy Lifestyle
Discover easy meal solutions for busy individuals seeking to maintain a healthy diet without sacrificing time. This blog post explores...